Cancer Detection Programs: Every Woman Counts Cancer Detection Programs: Every Woman Counts -- Provider Resource Homepage top five color bar
  Home Contact Us Site Index Search
people 1
 CANCER SCREENING
 & DIAGNOSIS
 
people 2
  TRAINING CENTER
  
 
  PROFESSIONAL
  RESOURCES
  Articles & Reviews
  Patient Education
  Clinical Tools
  Websites
   
people 4
  CDS PROGRAMS
 
 
people 5
  ABOUT US
 
 
  PROFESSIONAL
  RESOURCES
  Articles & Reviews
 
  Breast Cancer
Cervical Cancer
  Patient Education
  Clinical Tools
 
  Breast Cancer Tools
Cervical Cancer Tools
  Websites
 

Articles and Reviews

This page provides links to selected abstracts, full-text articles, and other recommended reading for healthcare professionals involved with breast and cervical cancer screening and diagnosis. New topics will be added regularly. Please check back often.

All links lead to external websites and open in a new browser window. Please close the window to return to this page.

 

Breast Cancer:

 

 

Clinical Breast Exam

Barton MB, Harris R, Fletcher SW. (1999). The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA, Oct;282(13):1270-80. Abstract

Benincasa TA, King ES, Rimer BK, Bloom HS, Balshem A, James J, et al. (1996). Results of an office-based training program in clinical breast examination for primary care physicians. J Cancer Educ, Spring;11(1):25-31. Abstract

Bobo JK, Lee NC, Thames SF. (2000). Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998.  J Natl Cancer Inst, Jun;92(12):971-6. Abstract

Chalabian J, Dunnington G. (1998). Do our current assessments assure competency in clinical breast evaluation skills?  Am J Surg, Jun;175(6):497-502. Abstract

Day, N. (2008). The need for performance and standardization of the best clinical breast exam. The Journal for Nurse Practitioners, 4(5): 342-349. Abstract

Fletcher SW, O'Malley MS, Bunce LA. (1985). Physicians' abilities to detect lumps in silicone breast models. JAMA, Apr;253(15):2224-8. Abstract

Foster RS Jr, Worden JK, Costanza MC, Solomon LJ. (1992). Clinical breast examination and breast self-examination. Past and present effect on breast cancer survival. Cancer, Apr;69(7 Suppl):1992-8. Review. Abstract

Goodson III, WH, (1996). Topics in primary care medicine: clinical breast examination. West J Med, 164:355-358. Full Text (pdf)

Goodson, III, WH, Moore, II, DH. (2002). Overall clinical breast examination as a factor in delayed diagnosis of breast cancer. Arch Surg, 137:1152-1156. Abstract Full Text 

McDonald S, Saslow D, Alciati MH. (2004). Performance and reporting of clinical breast examination: a review of the literature. CA Cancer J Clin, Nov-Dec;54(6):345-61. Review. Abstract

Miller AB, To T, Baines CJ, Wall C. (2000). Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years.
J Natl Cancer Inst, Sep;92(18):1490-9. Abstract

Pennypacker HS, Naylor L, Sander AA, Goldstein MK. (1999). Why can't we do better breast examinations? Nurse Pract Forum, Sep;10(3):122-8. Abstract

Saslow D, Hannan J, Osuch J, Alciati, MH, Baines, C, Barton, M, et al. (2004). Clinical breast examination: practical recommendations for optimizing performance and reporting.CA Cancer J Clin, Nov-Dec;54(6):327-44. Abstract

Wallace AE, MacKenzie TA, Weeks WB. (2006). Women's primary care providers and breast cancer screening: who's following the guidelines? Am J Obstet Gynecol, Mar;194(3):744-8. Abstract

Top of page

Hormone Replacement Therapy

Chlebowski RT, Anderson G, Pettinger M, Lane D, Langer RD, Gilligan MA, Walsh BW, Chen C, McTiernan A; Women's Health Initiative Investigators (2008). Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy. Arch Intern Med, Feb 25;168(4):370-7; quiz 345. Erratum in: Arch Intern Med. 2008 May 12;168(9):935. Gillian, Mary Ann [corrected to Gilligan, Mary Ann]. Abstract

Top of page

Cervical Cancer:

Human Papillomavirus (HPV)

Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). (2007). Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep, Mar 23;56(RR-2):1-24.

Genital human papillomavirus (HPV) is the most common sexually transmitted infection in the United States. Although the majority of infections cause no symptoms and are self-limited, infection with certain HPV types is considered necessary for the development of cervical cancer. In June 2006, the quadrivalent HPV vaccine types 6, 11, 16, 18 was licensed for use among females, ages 9 to 26 years, for prevention of vaccine HPV-type-related cervical cancer, cervical cancer precursors, vaginal and vulvar cancer precursors, and anogental warts. In March, 2007, the Advisory Committee on Immunization Practices (ACIP) published its first statement on the use of this vaccine..

Read the full text report at the Centers for Disease Control and Prevention (CDC) website.

Top of page

Reviewed: December 20, 2011

 

 

 
Center for Cancer Quality Assurance and Professional Education Homepage

Top of page

 
   
bottom five color bar
Search Site Index Terms Privacy ©2012 Copyright State of California. All rights reserved.